Physician profile
Marie Chen
NPI 1568516961
$1,475.51
in general payments reported to CMS, 2019-2025
14 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.67 · 2022: $77.51 · 2023: $193 · 2024: $654 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $489.19 | 2022-2025 | Localizer, Trident Specimen Radiography System, Trunode |
| Merit Medical Systems INC | $283.59 | 2020-2025 | Savi Scout |
| Dilon Technologies, INC. | $240.05 | 2024-2025 | Hemoblast Bellows |
| Axogen | $152.98 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Connector |
| Astrazeneca Pharmaceuticals Lp | $66.05 | 2025 | |
| Organogenesis INC. | $43.80 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $40.89 | 2024-2025 | Caldolor |
| Boston Scientific Corporation | $32.87 | 2024 | Varithena Administration Pack |
| Tactile Systems Technology INC | $25.92 | 2025 | Nimbl, Flexitouch Plus |
| Medtronic, INC. | $22.79 | 2023 | Plasmablade(Tm) |
| Merck Sharp & Dohme LLC | $20.55 | 2024 | Bridion |
| Myriad Genetic Laboratories, INC. | $19.72 | 2024 | Myrisk |
| Elucent Medical | $19.11 | 2025 | |
| Kub Technologies INC. | $18.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.